Letter to the editor: Comments on ‘A six-weekly dosing schedule for pembrolizumab in patients with cancer based on evaluation using modelling and simulation’
| Autor: | Ruben Malmberg, Meta H.M. Diekstra, Roelof W F van Leeuwen, Stefan Sleijfer |
|---|---|
| Přispěvatelé: | Pharmacy, Medical Oncology |
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: |
Cancer Research
Schedule medicine.medical_specialty Letter to the editor business.industry MEDLINE Cancer Pembrolizumab medicine.disease Antibodies Monoclonal Humanized Oncology SDG 3 - Good Health and Well-being Neoplasms medicine Humans In patient Medical physics Computer Simulation Dosing business |
| Zdroj: | European Journal of Cancer, 138, 54-56. Elsevier Ltd. |
| ISSN: | 1879-0852 0959-8049 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect